Results 171 to 180 of about 5,946,067 (288)

TSH suppression attenuates the early efficacy of zoledronic acid in osteoporosis. [PDF]

Arch Osteoporos
Liu Y, Zhang Y, Li M, Qian Y, Zhang Z, Jiang Z, Qu W.   +6 more
europepmc   +1 more source

Severe Hypocalcemia After the Administration of Zoledronic Acid for Osteoporotic Fracture

, 2016
Do‐Hee Kim
openalex   +2 more sources

Hesperetin modulates osteoprogenitor cells and macrophages under zoledronic acid and inflammatory stress. [PDF]

Arch Oral Biol
Mendes Soares IP, Liepman O, Anselmi C, Chang S, Hebling J, Dal-Fabbro R, Bottino MC.   +6 more
europepmc   +1 more source

Case report of severe hypocalcemia with atypical symptoms after zoledronic acid in palliative care: a deprescribing pitfall. [PDF]

BMC Palliat Care
Arnold T, Berner-Sharma J, Rudolph D, Bausewein C, Rémi C.   +4 more
europepmc   +1 more source

Bone marrow osteoprogenitors are depleted whereas osteoblasts are expanded independent of the osteogenic vasculature in response to zoledronic acid

, 2019
Russell Hughes, Xinyue Chen, Keith D. Hunter, Jamie K. Hobbs, Ingunn Holen, Nicola J. Brown   +5 more
openalex   +2 more sources

The Complex of Copper (II) and Zoledronic Acid: Relevance to Oxidative Death of Leukemia Cells in the Bone Marrow. [PDF]

Int J Mol Sci
Barskaya ES, Savin AM, Chernov KV, Petrova AS, Abramovich MS, Maksimova YA, Dubenskiy AS, Tsymbal SA, Lantsova AV, Moiseeva AA, Beloglazkina MA, Borisov RS, Beloglazkina EK, Shtil AA.   +13 more
europepmc   +1 more source

Early Denosumab Administration after Distal Radius Fractures in Postmenopausal Women: A Retrospective Comparison with Zoledronic Acid. [PDF]

Clin Orthop Surg
Kang HT, Kwon HY, Kang HJ.
europepmc   +1 more source

Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

, 2009
Marta Coscia, Elena Quaglino, Manuela Iezzi, Claudia Curcio, Francesca Pantaleoni, Chiara Riganti, Ingunn Holen, Hannu Mönkkönen, Mario Boccadoro, Guido Forni, Piero Musiani, Amalia Bosìa, Federica Cavallo, Massimo Massaia   +13 more
openalex   +2 more sources

Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study [PDF]

, 2019
Sahar Nasser, Arwa Sahal, Anas Hamad, Shereen Elazzazy   +3 more
openalex   +1 more source

Protocol summary and statistical analysis plan for the bone loss prevention with zoledronic acid or denosumab in critically ill adults (BONE ZONE) trial. [PDF]

Crit Care Resusc
Orford N, Serpa Neto A, Nair P, Bone A, Center JR, Hodgson C, Kotowicz MA, Litton E, Reynolds C, Trapani T, Young P, Venkatesh B, Bone Zone Investigators, ANZICS Clinical Trials Group.   +13 more
europepmc   +1 more source